From Risk to Resilience: The Voyage of Just Culture in the Workplace
Timothy D. Averch, MD, FACS, FRCS (Glasg), examines the transition from a punitive approach to a just culture in healthcare.
Read MoreSelect Page
Posted by Timothy D. Averch, MD, FACS, FRCS (Glasg) | Jun 2025
Timothy D. Averch, MD, FACS, FRCS (Glasg), examines the transition from a punitive approach to a just culture in healthcare.
Read MorePosted by Amy Krambeck, MD | May 2025
Amy E. Krambeck, MD, discusses the metabolic management of kidney stones and provides a comprehensive overview of pharmacologic treatments.
Read MorePosted by Gopalkumar Iyer, MD | May 2025
Gopalkumar Iyer, MD, explores the role of genomic alterations in predicting response to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Read MorePosted by Tanya B. Dorff, MD | May 2025
Tanya B. Dorff, MD, explores treatment for metastatic hormone-sensitive prostate cancer, emphasizing doublet and triplet therapies.
Read MorePosted by David M. Albala, MD | May 2025
David M. Albala, MD, discusses PSMA PET imaging in clinical practice, emphasizing the disruptive technology in managing prostate cancer.
Read More